Industry

Life Sciences

Optimize all stages of the life sciences journey

Life sciences executives face growing complexities due to heightened regulatory demands and intensified competition, adding to their already challenging daily responsibilities. As a trusted and innovative partner, we provide biotechnology, medical device, and pharmaceutical companies with tailored, cross-functional solutions at every stage of development, driving growth while ensuring compliance.

Create future financial value today. Here’s how.

Deliver scalable and forward-looking solutions for the Office of the CFO to:  

  • Establish and optimize operational infrastructure 
  • Support workforce planning during rapid transformation 
  • Add expert transaction experience 
  • Accelerate time-to-decision and time-to-market 

Cut through the complexities of technical accounting and financial reporting to draft audit-ready position papers for:  

  • Collaboration agreements 
  • Debt and equity financings 
  • Business combinations 

Support the clinical trial process with multi-disciplinary accounting guidance every step of the way. We collaborate with you to generate policies, procedures, reports, analyses, records, and statements leveraging leading practices in:  

  • Operational accounting 
  • FP&A 
  • Internal controls 

Stand up a public-ready finance team capable of executing a successful and efficient transaction, such as IPO/SPAC, divestiture, or M&A. Our team establishes and maintains SEC reporting and implements critical internal controls that keep you ahead of the regulatory curve. 

Implement software that meets current and future needs. We partner with technology leaders to integrate top ERP, procurement, automation, analytics, and financial reporting tools into your tech stack and corporate architecture for maximum data visibility, accessibility, and efficacy.

Optimize risk management programs across the business. Design custom security frameworks that empower you to anticipate, monitor, and respond to evolving cyber threats.

Unlocking real-world value for clients

Close optimization and audit readiness improves investor trust for a high-growth cancer-detection BioTech.

2023 SEC Private Fund Adviser Reforms: Summary of Changes

Material Weakness Remediation for Emerging-Growth Companies: What to Know and Where to Begin

Forward
Thinking

Technology-Enabled Transformation

8 CECL Questions Private Companies Need Answered

CREDSON

How do you create present and future value for your business?

Unlock core business value from a suite of integrated solutions expertly designed for organizations like yours.

Accouting & Risk

Anticipate and respond to complex regulatory and reporting requirements.

Technology-Enabled Transformation

Accelerate enterprise performance through people-led digital transformations.

Transactions

Manage transaction lifecycles for maximum deal value and minimum risk.

Contact us

Scroll to Top